Featured article:
Forty-five-year evolution of probiotic therapy
Scarlett Puebla-Barragan and Gregor Reid
In the past forty-five years, the field of probiotics has grown from a handful of laboratory studies and clinical ideas into a legitimate research and translational entity conferring multiple benefits to humans around the world. This has been founded upon three principles: (i) the need for alternatives to drugs that either have sub-optimal efficacy or severe adverse effects; (ii) a growing interest in natural products and microbes, in particular catalyzed by studies showing the extent of microbes within humans and on our planet; and (iii) evidence on the genetics and metabolic properties of probiotic strains, and clinical studies showing their effectiveness. While some manufacturers have sadly taken advantage of the market growth to sell supplements and foods they term probiotic, without the necessary human study evidence, there are more and more companies basing their formulations on science. Adherence to the definition of what constitutes a (…)
About us
News
The publisher
Meet the editorial board
Most viewed last month
- Hepatitis B virus and its sexually transmitted infection – an update
- Formyl-methionine as a degradation signal at the N-termini of bacterial proteins
- Understanding structure, function, and mutations in the mitochondrial ATP synthase
- Live fast, die soon: cell cycle progression and lifespan in yeast cells
- Guidelines and recommendations on yeast cell death nomenclature
- Forty-five-year evolution of probiotic therapy
- Guidelines for DNA recombination and repair studies: Cellular assays of DNA repair pathways
- Pathways of host cell exit by intracellular pathogens
- Autophagy: machinery and regulation
- Microbial competition between Escherichia coli and Candida albicans reveals a soluble fungicidal factor
Publish with MIC
Connect with us
